Myriad Genetics (MYGN) Tax Provisions (2009 - 2025)

Myriad Genetics has disclosed Tax Provisions across 17 years of filings, most recently posting -$1.0 million for Q4 2025.

• In Q4 2025, Tax Provisions fell 129.41% year-over-year to -$1.0 million; the TTM figure through Mar 2026 stood at $100000.0 (up 100.39% YoY), while the FY2025 annual figure was -$29.2 million, down 868.42% from the prior year.
• Tax Provisions slipped to -$1.0 million in Q4 2025, from $1.2 million in the prior quarter.
• Over the last five years, Tax Provisions for MYGN reached as high as $15.2 million in Q3 2021 and fell as low as -$35.9 million in Q4 2021.
• The 5-year median for Tax Provisions is -$500000.0 (2024), against an average of -$4.4 million.
• Annual changes were most pronounced in 2024 — Tax Provisions jumped 800.0% — and 2025, when it plunged 29400.0%.
• A 5-year view of Tax Provisions shows it stood at -$35.9 million in 2021, then surged by 72.7% to -$9.8 million in 2022, then jumped by 88.78% to -$1.1 million in 2023, then soared by 409.09% to $3.4 million in 2024, then sank by 129.41% to -$1.0 million in 2025.
• According to Business Quant data, Tax Provisions over the past three periods registered -$1.0 million, $1.2 million, and -$100000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.